Clinical trial
Rectal Non-steroid Anti-inflammatory Drugs With or Without Prophylactic Pancreatic Duct Stent for Prevention of Post-ERCP Pancreatitis: a Multicenter, Randomized, Non-inferiority Trial
NCT07117318 is registered in ClinicalTrials.gov with Air Force Military Medical University, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rectal Non-steroid Anti-inflammatory Drugs With or Without Prophylactic Pancreatic Duct Stent for Prevention of Post-ERCP Pancreatitis: a Multicenter, Randomized, Non-inferiority Trial
- Lead sponsor
- Air Force Military Medical University, China
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 1, 2025
- Completion date
- June 1, 2028
- Enrollment
- 1,278 (estimated)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
non-steroid anti-inflammatory drugs, pancreatic duct stent placement, post-ercp acute pancreatitis